Anti-apoptotic Bfl-1 is the major effector in activation-induced human mast cell survival

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Ekoff, Maria ^a   Lyberg, Katarina ^a   Krajewska, Maryla ^b   Arvidsson, Monica ^c   Rak, Sabina ^c   Reed, John C ^b   Harvima, Ilkka ^d   Nilsson, Gunnar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b BURNHAM INSTITUTE   (United States)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; BCL2 RELATED PROTEIN A1; IMMUNOGLOBULIN E RECEPTOR; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL XL; PROTEIN MCL 1; ROSCOVITINE; SMALL INTERFERING RNA;

ALLERGY TEST; ANTIBODY AFFINITY; ARTICLE; ATOPIC DERMATITIS; CELL ACTIVATION; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAST CELL; POLLEN ALLERGY; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PSORIASIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UMBILICAL CORD BLOOD;

CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; MAST CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84862490477     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039117     Document Type: Article

References (30)

1. Metcalfe DD, Baram D, Mekori YA, (1997) Mast cells. Physiol Rev 77: 1033-1079.
2. Galli SJ, (2000) Allergy. Curr Biol 10: R93-95.
3. Ishizaka T, Ishizaka K, (1984) Activation of mast cells for mediator release through IgE receptors. In: Ishizaka K, editors. pp. 188-235 editor. Mast Cell Activation and Mediator Release. Basel: Karger.
4. Kobayasi T, Asboe-Hansen G, (1969) Degranulation and regranulation of human mast cells. An electron microscopic study of the whealing reaction in urticaria pigmentosa. Acta Derm Venereol 49: 369-381.
5. Dvorak AM, Schleimer RP, Lichtenstein LM, (1987) Morphologic mast cell cycles. Cell Immunol 105: 199-204.
6. Kawakami T, Galli SJ, (2002) Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2: 773-786.
7. Kitaura J, Xiao W, Maeda-Yamamoto M, Kawakami Y, Lowell CA, et al. (2004) Early divergence of Fc epsilon receptor I signals for receptor up-regulation and internalization from degranulation, cytokine production, and survival. J Immunol 173: 4317-4323.
8. Xiang Z, Ahmed AA, Moller C, Nakayama K, Hatakeyama S, et al. (2001) Essential role of the prosurvival bcl-2 homologue A1 in mast cell survival after allergic activation. J Exp Med 194: 1561-1569.
9. Yoshikawa H, Nakajima Y, Tasaka K, (1999) Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression. J Immunol 162: 6162-6170.
10. Alfredsson J, Puthalakath H, Martin H, Strasser A, Nilsson G, (2005) Proapoptotic Bcl-2 family member Bim is involved in the control of mast cell survival and is induced together with Bcl-X(L) upon IgE-receptor activation. Cell Death Differ 12: 136-144.
11. Möller C, Xiang Z, Nilsson G, (2003) Activation of mast cells by immunoglobulin E-receptor cross-linkage, but not through adenosine receptors, induces A1 expression and promotes survival. Clin Exp Allergy 33: 1135-1140.
12. Xiang Z, Moller C, Nilsson G, (2006) IgE-receptor activation induces survival and Bfl-1 expression in human mast cells but not basophils. Allergy 61: 1040-1046.
13. Berent-Maoz B, Salemi S, Mankuta D, Simon HU, Levi-Schaffer F, (2008) TRAIL mediated signaling in human mast cells: the influence of IgE-dependent activation. Allergy 63: 333-340.
14. Karlberg M, Xiang Z, Nilsson G, (2008) Fc gamma RI-mediated activation of human mast cells promotes survival and induction of the pro-survival gene Bfl-1. J Clin Immunol 28: 250-255.
15. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, et al. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435: 677-681.
16. MacCallum DE, Melville J, Frame S, Watt K, Anderson S, et al. (2005) Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1. Cancer Res 65: 5399-5407.
17. Raje N, Kumar S, Hideshima T, Roccaro A, Ishitsuka K, et al. (2005) Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma. Blood 106: 1042-1047.
18. van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, et al. (2006) The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10: 389-399.
19. Ortiz-Ferron G, Yerbes R, Eramo A, Lopez-Perez AI, De Maria R, et al. (2008) Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism. Cell Res 18: 664-676.
20. Nilsson G, Blom T, Harvima I, Kusche-Gullberg M, Nilsson K, et al. (1996) Stem cell factor-dependent human cord blood derived mast cells express alpha- and beta-tryptase, heparin and chondroitin sulphate. Immunology 88: 308-314.
21. Saito H, Ebisawa M, Sakaguchi N, Onda T, Iikura Y, et al. (1995) Characterization of cord-blood-derived human mast cells cultured in the presence of Steel factor and interleukin-6. Int Arch Allergy Immunol 107: 63-65.
22. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, et al. (2003) Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 27: 677-682.
23. Nilsson G, Costa JJ, Metcalfe DD, (1999) Mast Cells and Basophils. In: Gallin JI, Snyderman R, editors. pp. 97-117 editors. Inflammation: Basic Principles and Clinical Correlates. 3rd ed. ed. Philadelphia: Lippincott Williams & Wilkins.
24. Diaconu NC, Kaminska R, Naukkarinen A, Harvima RJ, Nilsson G, et al. (2007) Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma. Cancer Immunol Immunother 56: 1407-1415.
25. Ackermann L, Harvima IT, (1998) Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis. Arch Dermatol Res 290: 353-359.
26. Alfredsson J, Moller C, Nilsson G, (2006) IgE-receptor activation of mast cells regulates phosphorylation and expression of forkhead and Bcl-2 family members. Scand J Immunol 63: 1-6.
27. Barker JN, (1991) The pathophysiology of psoriasis. Lancet 338: 227-230.
28. Tkaczyk C, Okayama Y, Woolhiser MR, Hagaman DD, Gilfillan AM, et al. (2002) Activation of human mast cells through the high affinity IgG receptor. Mol Immunol 38: 1289-1293.
29. Schendel SL, Azimov R, Pawlowski K, Godzik A, Kagan BL, et al. (1999) Ion channel activity of the BH3 only Bcl-2 family member, BID. J Biol Chem 274: 21932-21936.
30. Fischer M, Harvima IT, Carvalho RF, Moller C, Naukkarinen A, et al. (2006) Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J Clin Invest 116: 2748-2756.